Webinars

Webinars

Circulating Tumor Cells Circa 2022

Speaker
Daniel E. Sabath, MD, PhD
University of Washington Department of Laboratory Medicine and Pathology

Detecting small numbers of tumor cells is technically challenging, especially for patients with solid tumors, where very small numbers of tumor cells are present in the peripheral blood, even in patients with widely metastatic disease. In this presentation, Dr. Sabath will describe various technologies for detecting circulating tumor cells and data suggesting clinical utility. In particular, his laboratory's clinical validation of a circulating tumor cell assay using density gradient centrifugation to enrich for circulating tumor cells. Dr. Sabath will also discuss possible future applications of this technology.


Webinar slide


Webinars On-Demand

Unlock Spatial Biology with Orion Technology: Explore the possibilities for research and clinical applications

Webinar slide

Tissue consists of heterogenous cell types, each with diverse functions and functional states, arranged spatially in a way that impacts patient health status. Resolving this complexity at the subcellular level has historically been challenged by image resolution, the number of targets that can be simultaneously assessed, and throughput. Orion™ technology breaks these barriers by providing the fastest path to whole slide, high-plex imaging which will be shown in this webinar.



Multiplexed Tissue Imaging using the Orion Platform to Reveal the Spatial Biology of Cancer

Webinar slide

Recent developments in tissue imaging technologies have made available new tools that promise to advance our understanding of human disease and help guide the development and implementation of new therapies. This interactive webinar will focus on the use of multiplexed antibody-based tissue imaging of multiple antigens at single cell resolution using both cyclic immunofluorescence (CyCIF) and Orion high-plex imaging and the use of this data to identify cell lineages and states (molecular phenotypes) and map their spatial organization and interactions at different scales.




Patient Treatment Selection & Disease Monitoring by CTC enumeration
 

Join our expert panelists and learn from their experience utilizing the RareCyte platform for CTC enumeration, biomarker expression and single cell sequencing. Specifically addressing how CTC detection is possible in multiple types of GI tumors such as colorectal, esophageal, cholangiocarcinoma and pancreatic cancer.


Webinar slide


Circulating Tumor Cell Analysis: Delivering on the Promise of Liquid Biopsy

Webinar slide

CTC analysis via liquid biopsy (blood) allows for a less-invasive method to identify cancer cells and can prove helpful in prognosis, treatment selection, patient stratification, and patient monitoring. Our two distinguished speakers, with over 50 years of combined experience in the field, will walk through these applications and supporting data.


WATCH THE WEBINAR

Resolving the Complexity of Tissue Immune Response with Orion High-Dimensional Imaging

High-dimensional imaging allows identification of immune cell sub-types for investigation of cell number, density, proximity, and activation state. The breakthrough Orion platform generates same-day whole-slide images with sub-cellular imaging resolution in a single stain, single scan workflow with customizable staining panels. This webinar describes the application of 17-plex immuno-oncology fluorescence panel and H & E images on the same tissue sections for investigation of the complexity of immune response in normal and malignant tissues.


Webinar slide


Analytical Validation of CTC Enumeration using the RareCyte Platform and Implementation in a Global Clinical Trial

Webinar slide

This webinar describes how the RareCyte platform for CTC analysis was validated in the Clinical Diagnostics Lab (CAP accredited CLIA Lab) at Eli Lilly. The results met the requirements of the Clinical Drug Study Team and the RareCyte platform was added to a global clinical trial for further evaluation in collaboration with a CRO. A short presentation on RareCyte CTC assays for enumeration, multi-biomarker analysis, and custom assay development capabilities follows.


WATCH THE WEBINAR